EE200400030A - Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseks - Google Patents
Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseksInfo
- Publication number
- EE200400030A EE200400030A EEP200400030A EEP200400030A EE200400030A EE 200400030 A EE200400030 A EE 200400030A EE P200400030 A EEP200400030 A EE P200400030A EE P200400030 A EEP200400030 A EE P200400030A EE 200400030 A EE200400030 A EE 200400030A
- Authority
- EE
- Estonia
- Prior art keywords
- metastasis
- preventing
- cancer invasion
- matrix metalloproteinase
- treating cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35131702P | 2002-01-23 | 2002-01-23 | |
PCT/EP2003/000659 WO2003062413A1 (en) | 2002-01-23 | 2003-01-23 | Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200400030A true EE200400030A (et) | 2004-04-15 |
Family
ID=27613485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200400030A EE200400030A (et) | 2002-01-23 | 2003-01-23 | Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseks |
Country Status (22)
Country | Link |
---|---|
US (1) | US8012935B2 (pt) |
EP (1) | EP1468085B1 (pt) |
JP (1) | JP2005515262A (pt) |
KR (1) | KR20040077764A (pt) |
CN (2) | CN1622992A (pt) |
AT (1) | ATE425247T1 (pt) |
BR (1) | BR0302819A (pt) |
CA (1) | CA2472775A1 (pt) |
DE (1) | DE60326539D1 (pt) |
EE (1) | EE200400030A (pt) |
ES (1) | ES2324027T3 (pt) |
HR (1) | HRP20040732A2 (pt) |
IL (1) | IL162714A0 (pt) |
LV (2) | LV13289B (pt) |
MX (1) | MXPA04007170A (pt) |
NO (1) | NO20034146L (pt) |
NZ (1) | NZ533738A (pt) |
PL (1) | PL209827B1 (pt) |
RU (1) | RU2346043C2 (pt) |
WO (1) | WO2003062413A1 (pt) |
YU (1) | YU76403A (pt) |
ZA (1) | ZA200405328B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2856598B1 (fr) * | 2003-06-25 | 2005-10-28 | Inst Nat Sante Rech Med | Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale |
JP4911950B2 (ja) * | 2005-11-07 | 2012-04-04 | 晃 伊東 | Mmp−1の部分ペプチドを用いた癌浸潤・転移阻害薬 |
CA2754635C (en) * | 2009-03-06 | 2018-06-19 | Universite Paris Descartes | Use of gingival fibroblast conditioned media to treat metastatic cancer |
US8593732B1 (en) * | 2010-01-23 | 2013-11-26 | Lightsmyth Technologies, Inc. | Partially metallized total internal reflection immersion grating |
US8003110B1 (en) * | 2011-01-24 | 2011-08-23 | Matthias W. Rath | Metalloproteinase oligopeptides and their therapeutic use |
EP2649985A1 (en) * | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (III) |
US20140017267A1 (en) * | 2012-07-13 | 2014-01-16 | Matthias W Rath | Metalloproteinase oligopeptides and their therapeutic use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
GB8817075D0 (en) * | 1988-07-18 | 1988-08-24 | Raychem Ltd | Oscillation suppressor |
US5646027A (en) * | 1994-09-08 | 1997-07-08 | Warner-Lambert Company | Process for the production of gelatinase catalytic domain protein |
EP2275552B1 (en) * | 1999-10-29 | 2015-09-09 | GlaxoSmithKline Biologicals SA | Neisserial antigenic peptides |
-
2003
- 2003-01-23 PL PL371254A patent/PL209827B1/pl not_active IP Right Cessation
- 2003-01-23 JP JP2003562281A patent/JP2005515262A/ja active Pending
- 2003-01-23 EE EEP200400030A patent/EE200400030A/xx unknown
- 2003-01-23 IL IL16271403A patent/IL162714A0/xx unknown
- 2003-01-23 CN CNA038026899A patent/CN1622992A/zh active Pending
- 2003-01-23 WO PCT/EP2003/000659 patent/WO2003062413A1/en active IP Right Grant
- 2003-01-23 ES ES03702506T patent/ES2324027T3/es not_active Expired - Lifetime
- 2003-01-23 CA CA002472775A patent/CA2472775A1/en not_active Abandoned
- 2003-01-23 YU YU76403A patent/YU76403A/sh unknown
- 2003-01-23 AT AT03702506T patent/ATE425247T1/de active
- 2003-01-23 EP EP03702506A patent/EP1468085B1/en not_active Expired - Lifetime
- 2003-01-23 MX MXPA04007170A patent/MXPA04007170A/es not_active Application Discontinuation
- 2003-01-23 CN CNA2007100054389A patent/CN101007844A/zh active Pending
- 2003-01-23 NZ NZ533738A patent/NZ533738A/xx unknown
- 2003-01-23 BR BR0302819-4A patent/BR0302819A/pt not_active IP Right Cessation
- 2003-01-23 RU RU2004125599/13A patent/RU2346043C2/ru not_active IP Right Cessation
- 2003-01-23 DE DE60326539T patent/DE60326539D1/de not_active Expired - Lifetime
- 2003-01-23 KR KR10-2004-7011323A patent/KR20040077764A/ko not_active Application Discontinuation
- 2003-01-23 US US10/350,258 patent/US8012935B2/en not_active Expired - Fee Related
- 2003-09-17 NO NO20034146A patent/NO20034146L/no not_active Application Discontinuation
-
2004
- 2004-07-05 ZA ZA200405328A patent/ZA200405328B/en unknown
- 2004-08-13 HR HR20040732A patent/HRP20040732A2/hr not_active Application Discontinuation
- 2004-09-17 LV LVP-04-102A patent/LV13289B/en unknown
-
2005
- 2005-10-17 LV LVP-05-134A patent/LV13419B/lv unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005515262A (ja) | 2005-05-26 |
NO20034146L (no) | 2003-10-28 |
IL162714A0 (en) | 2005-11-20 |
MXPA04007170A (es) | 2004-10-29 |
LV13289B (en) | 2005-11-20 |
US20030139345A1 (en) | 2003-07-24 |
ZA200405328B (en) | 2006-03-29 |
EP1468085A1 (en) | 2004-10-20 |
PL371254A1 (en) | 2005-06-13 |
DE60326539D1 (de) | 2009-04-23 |
LV13419B (en) | 2006-09-20 |
NO20034146D0 (no) | 2003-09-17 |
ES2324027T3 (es) | 2009-07-29 |
ATE425247T1 (de) | 2009-03-15 |
YU76403A (sh) | 2006-05-25 |
CN101007844A (zh) | 2007-08-01 |
RU2346043C2 (ru) | 2009-02-10 |
NZ533738A (en) | 2006-03-31 |
WO2003062413A1 (en) | 2003-07-31 |
EP1468085B1 (en) | 2009-03-11 |
BR0302819A (pt) | 2004-04-27 |
RU2004125599A (ru) | 2005-07-10 |
US8012935B2 (en) | 2011-09-06 |
CA2472775A1 (en) | 2003-07-31 |
HRP20040732A2 (en) | 2005-06-30 |
KR20040077764A (ko) | 2004-09-06 |
PL209827B1 (pl) | 2011-10-31 |
CN1622992A (zh) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60333758D1 (de) | Prevention und Verringerung von Ischemia | |
CO6241137A2 (es) | Antagonistas ciclicos de peptido cxcr4 | |
MXPA04001033A (es) | Compuesto de sanado para heridas y anti-cancer. | |
NO20041700L (no) | Human koagulasjonsfaktor VII-polypeptider | |
MX2009008270A (es) | Polipeptido novedoso que tiene actividad anti-tumoral. | |
HRP20050585A2 (en) | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof | |
EP4306123A3 (en) | Saposin-a derived peptides and uses thereof | |
EE200400030A (et) | Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseks | |
RU2014134287A (ru) | Бифункциональный пептид | |
ATE531384T1 (de) | Peptide aus dem plasminogenaktivator-hemmer 1 und ihre verwendung | |
ATE411812T1 (de) | Peptide zur behandlung von infektionen mit dem herpes-virus | |
BR0113147A (pt) | Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos | |
LT2004079A (en) | Sythetic peptides and uses therof for the prevention and therapy of cancer invasion and metastasis | |
Łęgowska et al. | Peptomeric analogues of trypsin inhibitor SFTI-1 isolated from sunflower seeds | |
FR2858234B1 (fr) | Nouvel agent anti-angiogenique et son utilisation, notamment dans le cadre du traitement des cancers | |
NO20016341L (no) | Inhibitorer for integrinet <alfa>v<beta>6 | |
ATE544779T1 (de) | Neue, die migration dendritischer zellen induzierende polypeptide, sowie medikamente und pharmazeutische zusammensetzungen, die diese enthalten | |
WO2002053172A3 (en) | Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover | |
TH57872B (th) | สารยับยั้งของอินทีกริน อัลฟานู เบตา6 | |
Fucase | Purification and characterization of proteases inhibitors of Bitis gabonica rhinoceros venom with pharmacological potential | |
ATE400288T1 (de) | Peptide mit hohem cysteingehalt | |
Kapil et al. | Synthetic peptide as inhibitors of human complement activation | |
AU2003205658A1 (en) | Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis | |
ATE305478T1 (de) | Topoisomerase-ii inhibitoren |